Page last updated: 2024-11-07

paeonimetabolin i

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

paeonimetabolin I: metabolite of paeoniflorin; RN given for (2alpha,3abeta,5alpha,7abeta,8R*)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID127381
MeSH IDM0278385

Synonyms (6)

Synonym
paeonimetabolin i
99624-67-6
2,5-methano-1,3-benzodioxol-6(5h)-one, tetrahydro-3a-hydroxy-7a,8-dimethyl-, (2s-(2alpha,3abeta,5alpha,7abeta,8r*))-
3a-hydroxy-7a,8-dimethyltetrahydro-2h-2,5-methano-1,3-benzodioxol-6(3ah)-one
DTXSID70912585
8-hydroxy-3,10-dimethyl-2,9-dioxatricyclo[4.3.1.03,8]decan-5-one

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The times to Cmax (tmax) of PF were 11."( Pharmacokinetic study of paeonimetabolin I, a major metabolite of paeoniflorin from paeony roots.
Akao, T; Hattori, M; Heikal, OA; Takeda, S, 1997
)
0.6

Bioavailability

ExcerptReferenceRelevance
" The PF-metabolizing activity of intestinal bacteria was reduced to 16% and 33% of normal levels by treatment with AMPC-MET and ofloxacin, respectively, which caused alterations of that degree in the extent of absorption of PF and PM-I, but did not affect their rate of absorption or elimination."( Influence of co-administered antibiotics on the pharmacokinetic fate in rats of paeoniflorin and its active metabolite paeonimetabolin-I from Shaoyao-Gancao-tang.
Akao, T; He, JX; Tani, T, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]